Algo version: 0.98b
Dr. Lal PathLabs Limited is listed at the NSE Exchange
Dr. Lal PathLabs Limited [LALPATHLAB.NS]
NSE Sector: Healthcare Industry:Diagnostics & Research

Is Dr. Lal PathLabs Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Dr. Lal PathLabs Limited pays dividends. Last time was Friday 6th of September 2024 where the investors holding the stock on Tuesday 20th of August 2024 were paid INR6 per share. Over the last 19 times between 2016 and 2024, Dr. Lal PathLabs Limited has paid INR101.95 with an average of INR5.37 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Dr. Lal PathLabs Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR1 297.60, you would have made a profit of INR2 080.85 per share or 160.36%

Yes, the average daily trading liquidity for Dr. Lal PathLabs Limited is INR274 806 thousand. You should therefore be able to get in and out of your positions relatively fast.

Dr. Lal PathLabs Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.87, the company's ability to pay off the debt is good. Dr. Lal PathLabs Limited has a good net profit margin of 16.06% and should have high tolerances against inflation.

We have calculated the inflation risk for Dr. Lal PathLabs Limited to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.